SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 11.77 |
| Enterprise Value ($M) | 1.46 |
| Book Value ($M) | 8.19 |
| Book Value / Share | 0.56 |
| Price / Book | 1.44 |
| NCAV ($M) | 6.33 |
| NCAV / Share | 0.44 |
| Price / NCAV | 1.86 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.06 |
| Return on Assets (ROA) | -0.79 |
| Return on Equity (ROE) | -1.08 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.30 |
| Current Ratio | 2.30 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 12.53 |
| Assets | 14.39 |
| Liabilities | 6.20 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | CVI Investments, Inc. | 4.90 | -37.57 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 95,008 | 279,961 | 33.94 | |
| 109,750 | 283,222 | 38.75 | |
| 60,571 | 223,941 | 27.05 | |
| 73,074 | 236,804 | 30.86 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IMCC – IM Cannabis Corp. | IMMX – Immix Biopharma, Inc. |
| IMNM – Immunome, Inc. | IMTX – Immatics N.V. |
| INDP – Indaptus Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io